Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: rexnine who wrote (55)	2/7/2000 3:14:00 PM
From: scaram(o)uche	Respond to of 1833

There are many microfluidics approaches to HTS. In this instance, I feel that it was wise to pass on further support ($$$ burn) which would command the exclusive license. One needs access to microfluidics in combination with a proprietary assay method, but not certain that one needs to have exclusive access. That would be a very highly personal call. <g> Hard to say.... depends largely on whether or not Axiom can use the technology? If you're just beginning your studies, Axiom is a HTS company in San Diego, and KDUS owns a big chunk of it. Living Chip is at the bottom of my list of KDUS-related interests.